Search

Your search keyword '"neutropenia"' showing total 36,852 results

Search Constraints

Start Over You searched for: Descriptor "neutropenia" Remove constraint Descriptor: "neutropenia" Database OpenAIRE Remove constraint Database: OpenAIRE
36,852 results on '"neutropenia"'

Search Results

1. Management of acute colonic pseudo-obstruction in a neutropenic patient

2. Hypogammaglobulinaemia and B cell lymphopaenia in Barth syndrome

3. Long-term efficacy of weekly paclitaxel therapy in unresectable primary squamous cell carcinoma of the thyroid

4. Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial

5. Belantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma

6. Liposomal amphotericin B—the present

7. Neutropenia in Cynomolgus Monkeys With Anti-Drug Antibodies Associated With Administration of Afucosylated Humanized Monoclonal Antibodies

8. Copper deficiency, a rare but correctable cause of pancytopenia: a review of literature

9. Granulocyte-colony-stimulating Factor-resistant Neutropenia and Polyneuropathy Presenting as Severe Complications of Sjögren's Syndrome

10. Eficácia e tolerabilidade da imunoterapia em carcinoma nasofaríngeo avançado, com ou sem quimioterapia: uma metanálise

11. Afebrile chemotherapy-induced neutropenia: an international survey spots oncologists’ routine clinical practice versus the standard of care and the impact of COVID-19

12. Starting dose selection of palbociclib in Chinese patients with breast cancer based on population kinetic–pharmacodynamic model of neutropenia

13. Non-alcoholic fatty liver disease and thrombocytopenia IV: its association with granulocytopenia

14. A gain-of-function variant in the Wiskott-Aldrich syndrome gene is associated with a MYH9-related disease-like syndrome

15. The mouse homolog of the mutant WASp responsible for human X-linked neutropenia renders granulopoiesis ineffective

16. Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR

17. Midostaurin-induced Sweet syndrome in a patient with FLT3-ITD-positive AML

18. Homozygous DBF4 mutation as a cause of severe congenital neutropenia

19. A Protocol for Low-Input RNA-Sequencing of Patients with Febrile Neutropenia Captures Relevant Immunological Information

20. A multinational, drug utilization study of lipegfilgrastim use in real-world setting in Europe

21. Population pharmacokinetics of cisplatin in small cell lung cancer patients guided with informative priors

22. Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma

23. Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients

24. Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies

25. Hematologic abnormalities in Aicardi Goutières Syndrome

26. Relaxation of the criteria for entry to the UK Clozapine Central Non-Rechallenge Database: a modelling study

27. Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer

28. Impact of osteopenia and neutropenia in patients with colorectal cancer treated with FOLFOXIRI: a retrospective cohort study

29. PEG‐rhG‐CSF for prophylaxis of neutropenia after chemotherapy in patients with non–small cell lung cancer: A multicenter, prospective, randomized study

30. Efficacy and Safety of Apatinib plus Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cancer: A Phase II Trial

31. SLGT2 Inhibitor Rescues Myelopoiesis in G6PC3 Deficiency

32. A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer

33. Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study

34. Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis

35. Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial

36. Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study

37. Pure White Cell Aplasia Complicated by Systemic Sclerosis with Accompanying Scleroderma Renal Crisis

38. Effect of Lenalidomide Maintenance in Chronic Lymphocytic Leukemia: A Meta-Analysis and Trial-Sequential Analysis

39. Adverse events in lymphoma patients treated with phosphoinositide 3 kinase Inhibitor in clinical trials: a meta-analysis

40. Frequency of benign neutropenia among Black versus White individuals undergoing a bone marrow assessment

41. Platinum-based adjuvant therapy was efficient for triple-negative breast cancer: a meta-analysis from randomized controlled trials

42. Risk Factors for Palbociclib-Induced Early Developing Neutropenia in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

43. Genetic variations in low-to-medium-affinity Fcγ receptors and autoimmune neutropenia in early childhood in a Danish cohort

44. Rare case of pancrelipase therapy-induced neutropaenia

45. Management of chemotherapy-induced neutropenia in cancer patients

46. Pleural Fluid Analysis in Neutropenia

47. Association of UGT1A1*6 , UGT1A1*28 , or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis

48. Safety and Efficacy of Bendamustine and Rituximab (BR) Regimen in Indian Chronic Lymphocytic Leukaemia Patients

49. Central nervous system neurotoxicity associated with nelarabine in T-cell acute lymphoblastic leukemia

50. Model‐Based Prediction of Irinotecan‐Induced Grade 4 Neutropenia in Advanced Cancer Patients: Influence of Demographic and Clinical Factors

Catalog

Books, media, physical & digital resources